Table 1 Patient characteristics*
ICS/MON | ICS/LABA/MON | All Patients | |
|---|---|---|---|
Patient N (%) | 181 (52.6%) | 163 (47.4%) | 344 (100.0%) |
Years of age‡ | 30.4 ± 9.3 | 32.6 ± 9.4 | 31.5 ± 9.4 |
Male sex | 82 (45.3%) | 69 (42.6%) | 151 (44.0%) |
Current smoker | 6 (3.3%) | 10 (6.1%) | 16 (4.7%) |
Years since asthma diagnosed | 8.5 ± 7.6 | 8.0 ± 7.7 | 8.3 ± 7.7 |
Years since allergic rhinitis diagnosed‡ | 10.7 ± 8.2 | 8.4 ± 7.7 | 9.6 ± 8.1 |
Allergic rhinitis severity | |||
Mild intermittent | 60 (33.2%) | 64 (39.3%) | 124 (36.1%) |
Mild persistent | 87 (48.1%) | 74 (45.4%) | 161 (46.8%) |
Moderate-severe intermittent | 26 (14.4%) | 15 (9.2%) | 41 (11.9%) |
Moderate-severe persistent | 8 (4.4%) | 10 (6.1%) | 18 (5.2%) |
Months on therapy in prior 12 months | |||
ICS‡ | 10.5 ± 3.4 | 11.2 ± 2.4 | 10.8 ± 3.0 |
ICS/LABA‡ | 1.1 ± 3.2 | 8.0 ± 5.2 | 4.4 ± 5.5 |
Asthma- and allergic rhinitis-related medical resource use in prior 12 months | |||
Short-acting beta-agonist | 155 (85.6%) | 130 (79.8%) | 285 (82.9%) |
Oral corticosteroids | 21 (11.6%) | 24 (14.7%) | 45 (13.1%) |
Antibiotics | 38 (21.0%) | 44 (27.0%) | 82 (23.8%) |
Antihistamines | 129 (71.3%) | 104 (63.8%) | 233 (67.7%) |
Allergist visit‡ | 85 (47.0%) | 54 (33.1%) | 139 (40.4%) |
Pulmonologist visit | 1 (0.6%) | 1 (0.6%) | 2 (0.6%) |
Emergency Room visit | 34 (18.8%) | 23 (14.1%) | 57 (16.6%) |
Hospitalization | 7 (3.9%) | 3 (1.8%) | 10 (2.9%) |
Asthma attack† | 49 (27.1%) | 44 (27.0%) | 93 (27.0%) |
Months on therapy in 12-month follow-up‡ | 10.5 ± 2.9 | 11.4 ± 1.9 | 10.9 ± 2.5 |